BANYU PHARMACEUTICAL OBTAINS ADDITIONAL APPROVAL FOR NU-LOTAN TABLET

Banyu Pharmaceutical has obtained additional approval for NU-LOTAN Tablet 25mg/ 50mg (losartan potassium), its proprietary agent for treating hypertension, from the Ministry of Health, Labor and Welfare. The agent is now available for the treatment of diabetic nephropathy (DN).

Japan Corporate News Network (http://www.japancorp.net/Article.Asp?Art_ID=12375)